Pharmaceuticals, Biotechnology and Life Sciences
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in…
— Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years– BRISBANE,…
– Once-weekly TransCon® CNP and TransCon® hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks…
SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on…
NEW YORK–(BUSINESS WIRE)–GenNx360 Capital Partners (“GenNx360”), a New York City-based private equity firm investing in middle-market industrial and business services…
Approximately $35 million and $49 million unaudited global net product revenue of EKTERLY (sebetralstat) for the fourth quarter and full…
–Savara Submitted the MOLBREEVI Biologics License Application (BLA) in December 2025 for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis…
Investor Day on January 21, 2026, to present new product vision and AI solutions RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Simulations Plus,…
SASKATOON, Saskatchewan–(BUSINESS WIRE)–The Global Agri-Food Advancement Partnership (GAAP) is pleased to announce the signing of a Memorandum of Understanding (MOU)…
SAN FRANCISCO–(BUSINESS WIRE)–A new peer-reviewed study published in Cytotherapy, the official journal of the International Society for Cell & Gene…